To promote the inheritance and innovation of Chinese medicine and the high-quality development of the Chinese medicine industry, the Institute of Chinese Medical Sciences (ICMS) of the University of Macau (UM) and the Hubei University of Chinese Medicine (HBUCM) jointly organised a seminar on the inheritance and innovation of Chinese medicine. Experts, researchers, faculty members and students in the field attended the seminar to explore in depth the advantages of Chinese medicine in terms of economics, technology, culture, and ecological resources.
The seminar featured five presentations by scholars from UM and HBUCM, covering theoretical knowledge and clinical experience in the field of Chinese medicine. Liu Songlin, party committee secretary and president of HBUCM, stressed the importance of integrity and innovation in the development of Chinese medicine. Liu Hongtao, professor at HBUCM, shared his experience of using Chinese medicine to regulate intestinal microecology and treat metabolic diseases. Mei Guoqiang, professor at HBUCM, discussed the clinical application and compatibility of Xiao Xian Xiong Tang (Minor Chest-Draining Decoction). Chen Xin, director of ICMS, talked about the immune regulation mechanism in Chinese medicine. Wan Jianbo, assistant director of ICMS, presented research on the chemical defence system in Panax notoginseng.
In addition, the HBUCM delegation met with Yonghua Song, rector of UM, and had in-depth discussions on topics such as the implementation of research and development cooperation in Chinese medicine, commercialisation of research results, and talent cultivation. They also visited the State Key Laboratory of Quality Research in Chinese Medicine and the UM Library.
| Source: Institute of Chinese Medical Sciences | |
| Media Contact Information: | |
| Communications Office, University of Macau | |
| Albee Lei | Tel: (853) 8822 8004 |
| Jason Leong | Tel: (853) 8822 8322 |
| Email: | prs.media@um.edu.mo |
